“Same
disease,
very
different
access.”
—
Fei
Wang,
PhD,
of
Breakthrough
T1D
in
St.
Leonards,
Australia,
discussing
the
state-by-state
disparities
in
the
U.S.
in
terms
of
type
1
diabetes
incidence
and
access
to
pediatric
endocrinologists.
“Clinically
useful
but
imperfect.”
—
Yara
Abdou,
MD,
of
the
University
of
North
Carolina
in
Chapel
Hill,
on
PD-L1
expression
in
triple-negative
breast
cancer
and
the
need
for
better
biomarkers
to
guide
care.
“We
want
to
encourage
people
to
be
candid
about
their
mental
health
struggles.”
—
David
Pflaum,
MD,
of
Northwell
Health
Far
Rockaway
Treatment
Center
in
New
York
City,
remarking
after
the
news
of
Brad
Pitt’s
past
suicidal
ideation
on
how
celebrity
health
disclosures
can
benefit
the
public.
“It
is
not
a
zero-sum
game.”
—
Jonathan
Carter,
MD,
of
the
University
of
California
San
Francisco,
noting
how
prior
use
of
GLP-1
medications
likely
won’t
diminish
bariatric
surgery’s
weight-loss
benefits.
“Foreign-born
physicians
are
disproportionately
helping
to
serve
communities
that
have
more
difficulties
accessing
care.”
—
Giacomo
Meille,
PhD,
of
the
American
Board
of
Internal
Medicine,
on
research
showing
that
doctors
born
outside
the
U.S.
play
a
big
role
in
caring
for
underserved
patients.
“The
knee-jerk
reaction
of
advising
women
to
stop
medication
during
pregnancy
ignores
the
impact
of
the
underlying
illness
on
maternal-fetal
health.”
—
Katherine
Wisner,
MD,
of
the
Developing
Brain
Institute
at
Children’s
National
Hospital
in
Washington,
D.C.,
on
how
stopping
antidepressants
in
pregnancy
increases
risks
for
relapse,
maternal
medical
complications,
and
loss
of
function
and
resources.
“Fournier
gangrene
is
a
clinical
diagnosis,
not
a
demographic
diagnosis.”
—
Ali
Bassi,
MD,
MSc,
of
King
Saud
University
in
Riyadh,
Saudi
Arabia,
arguing
that
doctors
should
consider
the
rare
bacterial
infection
in
cases
of
rapidly
progressive
perineal
pain
and
swelling,
regardless
of
sex
or
immune
status.
“There
are
opportunities
to
improve
treatment
alignment
at
both
ends
of
the
glycemic
spectrum.”
—
Phuc
Le,
PhD,
MPH,
of
the
Cleveland
Clinic,
on
study
findings
that
most
older
adults
with
type
2
diabetes
whose
HbA1c
was
outside
guideline-recommended
ranges
did
not
receive
medication
tweaks.
Please
enable
JavaScript
to
view
the